United Homes Group, Inc - Class A Common Stock (UHG)
1.8000
-0.0700 (-3.74%)
NASDAQ · Last Trade: May 19th, 4:16 PM EDT

United Homes Gr just reported results for the second quarter of 2024.
Via InvestorPlace · August 8, 2024
Via Benzinga · May 9, 2025
Via Benzinga · April 8, 2025

Via Benzinga · December 6, 2024

Via Benzinga · August 5, 2024

United Homes Gr just reported results for the first quarter of 2024.
Via InvestorPlace · May 10, 2024

Via Benzinga · June 17, 2024

Via Benzinga · June 13, 2024

Via Benzinga · June 13, 2024

Via Benzinga · June 13, 2024

Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.
Via Benzinga · March 14, 2024

Via Benzinga · January 24, 2024

On Monday, 369 companies set new 52-week lows.
Via Benzinga · October 2, 2023

Via Benzinga · September 18, 2023

The most oversold stocks in the consumer discretionary sector presents an opportunity to buy into undervalued companies.
Via Benzinga · September 15, 2023

Gainers Tenon Medical, Inc. (NASDAQ: TNON) shares climbed 63.5% to $0.2351 after the company announced it has withdrawn its proposed public offering of shares of its common stock.
Via Benzinga · September 12, 2023

U.S. stocks traded lower, with the Dow Jones gaining around 90 points on Tuesday. Here are some big stocks recording gains in today’s session. Shengfeng Development Limited (NASDAQ: SFWL) shares jumped 45.3% to $13.53.
Via Benzinga · September 12, 2023

Monday's session saw 175 companies set new 52-week lows.
Via Benzinga · September 11, 2023

The most oversold stocks in the consumer discretionary sector presents an opportunity to buy into undervalued companies.
Via Benzinga · August 14, 2023

Gainers Vistagen Therapeutics, Inc. (NASDAQ: VTGN) shares jumped 747.6% to $14.24 after the company announced its Phase 3 PALISADE-2 trial evaluating the efficacy, safety, and tolerability of fasedienol met the primary and secondary endpoints.
Via Benzinga · August 7, 2023

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.
Via Benzinga · August 10, 2023